Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]
Authors Walling DP, Hassman HA, Anta L , Ochoa L, Ayani I, Martínez J , Gutierro I
Received 24 May 2022
Accepted for publication 24 May 2022
Published 13 June 2022 Volume 2022:16 Pages 1791—1792
Walling DP, Hassman HA, Anta L, et al. Drug Des Devel Ther. 2021;15:4371–4382.
Page 4378, Table 2, PK Parameter column, the text “Cave (ng/nL)” should read “Cave (ng/mL)”.
Page 4379, Table 3, PK Parameter column, the text “Cave (ng/nL)” should read “Cave (ng/mL)”.
The authors apologize for the errors.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.